Tianjin Lisheng Pharmaceutical Co Ltd
Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers its products in various forms comprising tablets, capsules, granules, and injections for use in various therapeutic fields, such as nervous system, musculoskeletal, genitourinary system, antineoplastic and immune system, … Read more
Tianjin Lisheng Pharmaceutical Co Ltd (002393) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.016x
Based on the latest financial reports, Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a cash flow conversion efficiency ratio of 0.016x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥81.14 Million) by net assets (CN¥5.00 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tianjin Lisheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Tianjin Lisheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tianjin Lisheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tianjin Lisheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Photo-Me International plc
F:PHQ
|
0.059x |
|
Genusplus Group Ltd
AU:GNP
|
0.609x |
|
BGT Group Co. Ltd.
SHE:300774
|
N/A |
|
ZJAMP Group Co Ltd
SHE:002758
|
0.078x |
|
Ciputra Development Tbk
JK:CTRA
|
0.033x |
|
Quality Houses Public Company Limited
BK:QH-R
|
0.006x |
|
QingCloud Technologies Corp.
SHG:688316
|
-0.197x |
|
Zorlu Enerji Elektrik Uretim AS
IS:ZOREN
|
-0.033x |
Annual Cash Flow Conversion Efficiency for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Tianjin Lisheng Pharmaceutical Co Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.80 Billion | CN¥88.26 Million | 0.018x | -56.96% |
| 2023-12-31 | CN¥4.90 Billion | CN¥209.51 Million | 0.043x | -43.92% |
| 2022-12-31 | CN¥4.35 Billion | CN¥331.38 Million | 0.076x | +71.15% |
| 2021-12-31 | CN¥4.41 Billion | CN¥196.34 Million | 0.045x | +150.77% |
| 2020-12-31 | CN¥4.30 Billion | CN¥76.37 Million | 0.018x | -70.78% |
| 2019-12-31 | CN¥4.42 Billion | CN¥268.33 Million | 0.061x | +19.96% |
| 2018-12-31 | CN¥3.21 Billion | CN¥162.69 Million | 0.051x | -12.99% |
| 2017-12-31 | CN¥3.08 Billion | CN¥179.25 Million | 0.058x | +1.09% |
| 2016-12-31 | CN¥3.02 Billion | CN¥173.60 Million | 0.058x | -13.70% |
| 2015-12-31 | CN¥2.97 Billion | CN¥198.13 Million | 0.067x | +168.73% |
| 2014-12-31 | CN¥2.91 Billion | CN¥72.24 Million | 0.025x | -74.94% |
| 2013-12-31 | CN¥2.92 Billion | CN¥289.62 Million | 0.099x | +10.09% |
| 2012-12-31 | CN¥2.79 Billion | CN¥250.72 Million | 0.090x | +87.07% |
| 2011-12-31 | CN¥2.80 Billion | CN¥134.58 Million | 0.048x | -31.68% |
| 2010-12-31 | CN¥2.65 Billion | CN¥186.55 Million | 0.070x | -83.10% |
| 2009-12-31 | CN¥470.87 Million | CN¥196.14 Million | 0.417x | +56.23% |
| 2008-12-31 | CN¥474.77 Million | CN¥126.59 Million | 0.267x | -34.13% |
| 2007-12-31 | CN¥432.23 Million | CN¥174.94 Million | 0.405x | -- |